Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) signed the share transfer agreement to acquire Guangzhou Xiehe Precision Medical Co., Ltd. from Guangzhou Kunlun Investment Co., Ltd. for CNY 1.5 billion on March 26, 2021. Xiangxue Pharmaceutical will pay CNY 450 million within 10 working days after the effective date of this agreement, CNY 375 million within 10 working days after the delivery date stipulated in the delivery of this agreement and CNY 675 million within 24 months from the date when the second phase of equity transfer price agreed in this agreement is paid. Guangzhou Xiehe Precision Medical reported total assets of CNY 2.4 billion and net assets of CNY 1.5 billion as of February 28, 2021. Board of Xiangxue Pharmaceutical approved the transaction.